» Articles » PMID: 35624892

The Systemic Effects of Exercise on the Systemic Effects of Alzheimer's Disease

Overview
Date 2022 May 28
PMID 35624892
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is a progressive degenerative disorder and a leading cause of dementia in the elderly. The etiology of AD is multifactorial, including an increased oxidative state, deposition of amyloid plaques, and neurofibrillary tangles of the tau protein. The formation of amyloid plaques is considered one of the first signs of the illness, but only in the central nervous system (CNS). Interestingly, results indicate that AD is not just localized in the brain but is also found in organs distant from the brain, such as the cardiovascular system, gut microbiome, liver, testes, and kidney. These observations make AD a complex systemic disorder. Still, no effective medications have been found, but regular physical activity has been considered to have a positive impact on this challenging disease. While several articles have been published on the benefits of physical activity on AD development in the CNS, its peripheral effects have not been discussed in detail. The provocative question arising is the following: is it possible that the beneficial effects of regular exercise on AD are due to the systemic impact of training, rather than just the effects of exercise on the brain? If so, does this mean that the level of fitness of these peripheral organs can directly or indirectly influence the incidence or progress of AD? Therefore, the present paper aims to summarize the systemic effects of both regular exercise and AD and point out how common exercise-induced adaptation via peripheral organs can decrease the incidence of AD or attenuate the progress of AD.

Citing Articles

Network pharmacology and metabolomics analysis of Tinospora cordifolia reveals BACE1 and MAOB as potential therapeutic targets for neuroprotection in Alzheimer's disease.

Amrutha S, Abhinand C, Upadhyay S, Parvaje R, Prasad T, Modi P Sci Rep. 2025; 15(1):8103.

PMID: 40057579 PMC: 11890609. DOI: 10.1038/s41598-025-92756-5.


Exploring the potential of probiotics in Alzheimer's disease and gut dysbiosis.

S S, L S D, Rajendran P, N H, S A IBRO Neurosci Rep. 2024; 17:441-455.

PMID: 39629018 PMC: 11612366. DOI: 10.1016/j.ibneur.2024.11.004.


Treadmill exercise can regulate the redox balance in the livers of APP/PS1 mice and reduce LPS accumulation in their brains through the gut-liver-kupffer cell axis.

Yuan S, Wang Y, Yang J, Tang Y, Wu W, Meng X Aging (Albany NY). 2024; 16(2):1374-1389.

PMID: 38295303 PMC: 10866404. DOI: 10.18632/aging.205432.


Exercise combined with postbiotics treatment results in synergistic improvement of mitochondrial function in the brain of male transgenic mice for Alzheimer's disease.

Kolonics A, Bori Z, Torma F, Abraham D, Feher J, Radak Z BMC Neurosci. 2023; 24(1):68.

PMID: 38110905 PMC: 10726509. DOI: 10.1186/s12868-023-00836-x.


Advancing Alzheimer's Therapeutics: Exploring the Impact of Physical Exercise in Animal Models and Patients.

Andrade-Guerrero J, Rodriguez-Arellano P, Barron-Leon N, Orta-Salazar E, Ledesma-Alonso C, Diaz-Cintra S Cells. 2023; 12(21).

PMID: 37947609 PMC: 10648553. DOI: 10.3390/cells12212531.


References
1.
Griffith C, Eid T, Rose G, Patrylo P . Evidence for altered insulin receptor signaling in Alzheimer's disease. Neuropharmacology. 2018; 136(Pt B):202-215. DOI: 10.1016/j.neuropharm.2018.01.008. View

2.
Radak Z, Young Chung H, Goto S . Systemic adaptation to oxidative challenge induced by regular exercise. Free Radic Biol Med. 2008; 44(2):153-9. DOI: 10.1016/j.freeradbiomed.2007.01.029. View

3.
Leblhuber F, Steiner K, Schuetz B, Fuchs D, Gostner J . Probiotic Supplementation in Patients with Alzheimer's Dementia - An Explorative Intervention Study. Curr Alzheimer Res. 2018; 15(12):1106-1113. PMC: 6340155. DOI: 10.2174/1389200219666180813144834. View

4.
Wang J, Gu B, Masters C, Wang Y . A systemic view of Alzheimer disease - insights from amyloid-β metabolism beyond the brain. Nat Rev Neurol. 2017; 13(10):612-623. DOI: 10.1038/nrneurol.2017.111. View

5.
de Oliveira J, Kucharska E, Garcez M, Rodrigues M, Quevedo J, Moreno-Gonzalez I . Inflammatory Cascade in Alzheimer's Disease Pathogenesis: A Review of Experimental Findings. Cells. 2021; 10(10). PMC: 8533897. DOI: 10.3390/cells10102581. View